TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
116
|
126
|
188 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
33
|
21
|
79 |
| EBITDA |
32
|
21
|
79 |
| Total assets |
197
|
233
|
234 |
| Current assets |
197
|
233
|
234 |
| Current liabilities |
1
|
19
|
3 |
| Equity capital |
190
|
208
|
224 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
96.4%
|
89.3%
|
95.7% |
| Turnover per employee |
116
|
126
|
188 |
| Profit as a percentage of turnover |
28.4%
|
16.7%
|
42.0% |
| Return on assets (ROA) |
16.8%
|
9.0%
|
33.8% |
| Current ratio |
19700%
|
1226.3%
|
7800% |
| Return on equity (ROE) |
17.4%
|
10.1%
|
35.3% |
| Change turnover |
0
|
-58
|
-17 |
| Change turnover % |
0%
|
-31%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.